Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;44:271-276
Published online before print August 9, 2004, doi: 10.1161/01.HYP.0000140058.28994.ec
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
44/3/271    most recent
01.HYP.0000140058.28994.ecv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verlohren, S.
Right arrow Articles by Gollasch, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verlohren, S.
Right arrow Articles by Gollasch, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*4-AMINOPYRIDINE
*BARIUM COMPOUNDS
*BARIUM, ELEMENTAL
*PHENYLEPHRINE
*POTASSIUM
Related Collections
Right arrow Lipids
Right arrow Obesity
Right arrow Hypertension - basic studies
Right arrow Ion channels/membrane transport
Right arrow Other Vascular biology

(Hypertension. 2004;44:271.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Visceral Periadventitial Adipose Tissue Regulates Arterial Tone of Mesenteric Arteries

Stefan Verlohren; Galyna Dubrovska; Suk-Ying Tsang; Kirill Essin; Friedrich C. Luft; Yu Huang; Maik Gollasch

From the Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine (S.V., G.D., K.E., F.C.L., M.G.), Charité University Hospitals, Humboldt University of Berlin, HELIOS Klinikum Berlin, Germany; Louisiana State University Health Sciences Center (M.G.), Department of Physiology, New Orleans; Department of Physiology (S.-Y.T.,Y.H.), Chinese University of Hong Kong, Shatin, China.

Correspondence to Maik Gollasch, MD, PhD, Franz Volhard Clinic, Wiltbergstraße 50, 13125 Berlin, Germany. E-mail gollasch{at}fvk-berlin.de or mgolla@lsuhsc.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Periadventitial adipose tissue produces vasoactive substances that influence vascular contraction. Earlier studies addressed this issue in aorta, a vessel that does not contribute to peripheral vascular resistance. We tested the hypothesis that periadventitial adipose tissue modulates contraction of smaller arteries more relevant to blood pressure regulation. We studied mesenteric artery rings surrounded by periadventitial adipose tissue from adult male Sprague-Dawley rats. The contractile response to serotonin, phenylephrine, and endothelin I was markedly reduced in intact vessels compared with vessels without periadventitial fat. The contractile response to U46619 or depolarizing high K+-containing solutions (60 mmol/L) was similar in vessels with and without periadventitial fat. The K+ channel opener cromakalim induced relaxation of vessels precontracted by serotonin but not by U46619 or high K+-containing solutions (60 mmol/L), suggesting that K+ channels are involved. The intracellular membrane potential of smooth muscle cells was more hyperpolarized in intact vessels than in vessels without periadventitial fat. Both the anticontractile effect and membrane hyperpolarization of periadventitial fat were abolished by inhibition of delayed-rectifier K+ (Kv) channels with 4-aminopyridine (2 mmol/L) or 3,4-diaminopyridine (1 mmol/L). Blocking other K+ channels with glibenclamide (3 µmol/L), apamin (1 µmol/L), iberiotoxin (100 nmol/L), tetraethylammonium ions (1 mmol/L), tetrapentylammonium ions (10 µmol/L), or Ba2+ (3 µmol/L) had no effect. Longitudinal removal of half the perivascular tissue reduced the anticontractile effect of fat by almost 50%, whereas removal of the endothelium had no effect. We suggest that visceral periadventitial adipose tissue controls mesenteric arterial tone by inducing vasorelaxation via Kv channel activation in vascular smooth muscle cells.


Key Words: muscle, smooth • mesenteric arteries • obesity • hypertension, obesity


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Periadventitial adipose tissue is routinely removed for contraction studies on isolated blood vessels. Soltis and Cassis demonstrated that periadventitial fat significantly attenuates vascular responsiveness of rat isolated aortic rings to norepinephrine.1 We confirmed the inhibitory action of periadventitial fat on aortic contraction. However, we also found that the effect is antagonized by depolarizing external high K+ solutions and partly by glibenclamide, suggesting that the anticontractile effects of fat are mediated in part by opening of ATP-dependent K+ (KATP) channels in aortic smooth muscle cells.2 The action was not dependent on NO synthesis or endothelium. The anticontractile effects did not require the cyclooxygenase or P450 pathway, activation of adenosine receptors, or functional leptin receptors.2 However, we found that relaxation was induced by a transferable adipocyte-derived relaxing factor (ADRF) released from periadventitial adipose tissue.2 The results were not obtained in vessels that contribute to peripheral vascular resistance, and thus, their relevance to hypertension is unclear. We tested the hypothesis that periadventitial fat modulates contraction of smaller peripheral arteries. We used isolated mesenteric artery rings surrounded by periadventitial adipose tissue from adult male Sprague-Dawley rats and performed isometric contraction measurements. We found that periadventitial fat significantly attenuated vascular responsiveness to several hormonal agonists. In contrast to the findings in aorta, visceral perivascular adipose tissue controlled mesenteric arterial tone by activating voltage-dependent, delayed-rectifier K+ (Kv) channels.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
An extended Methods section is available online at http://www.hypertensionaha.org.

Briefly, superior mesenteric arteries of male Sprague-Dawley rats (200 to 300 g, 6 to 8 weeks) were quickly transferred to cold (4°C) oxygenated (95% O2/5% CO2) physiological salt solution, and dissected into 2-mm rings as described previously, whereby periadventitial fat and connective tissue were either removed [(–) fat rings] or left intact [(+) fat rings].3,4 The periadventitial fat was removed with scissors,2 being careful not to damage the adventitia.5 In some experiments, 50% of the periadventitial fat was removed longitudinally along the ipsilateral side of the vessel ring with scissors; it was left intact on the contralateral side of the vessel ring. The organ bath was filled with physiological salt solution of the following composition (mol/L): 119 NaCl, 4.7 KCl, 1.2 KH2PO4, 25 NaHCO3, 1.2 Mg2SO4, 11.1 glucose, and 1.6 CaCl2 (95% O2 plus 5% CO2, 37°C, pH 7.4). The rings were placed in a small vessel wire myograph under an optimal resting tension of 2 mN.3,4 Tension is expressed as a percentage of the steady-state tension (100%) obtained with isotonic external 60 mmol/L KCl.

In the first series of experiments, the rings were exposed to increasing doses of serotonin (10–8 to 10–5 mol/L), endothelin I (10–9 to 10–7 mol/L), phenylephrine (3x10–9 to 10–5 mol/L), or U46619 (10–9 to 10–6 mol/L). In some experiments, we measured the concentration of serotonin in the bath solution of (+) fat and (–) fat vessels. After a 10-minute incubation period of (–) fat and (+) fat with 2 µmol/L serotonin, the serotonin concentration was not different in the bath solution between both groups (high-performance liquid chromatography analysis), indicating that the effects of perivascular fat are anticontractile and not because of partial degradation of the vasoconstrictor agent. In the second series of experiments, the effect of serotonin was investigated in rings pretreated with different K+ channel blockers. The effects were compared with contractions to 2 µmol/L serotonin 10 minutes before addition of the inhibitors. In the third series of experiments, the effects of cromakalim (100 nmol/L) were tested on 2 µmol/L serotonin- or 0.1 µmol/L U46619-induced contraction in rings following 10-minute exposure of serotonin or U46619.

Intracellular membrane potential was measured using sharp intracellular glass microelectrodes as previously described.6 The glass microelectrodes were prepared by means of a horizontal puller and filled with 3 mol/L KCl (tip resistance in the range of 40 to 60 M{Omega}). Impalement was from the adventitial side of each vessel.

All values are given as mean±SEM. Paired and unpaired Student t tests or ANOVA were used as appropriate. P<0.05 was considered statistically significant; n represents the number of arteries tested.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
Anticontractile Effect of Perivascular Adipose Tissue
To test the hypothesis that periadventitial fat influences vascular contraction, we generated dose-response curves to serotonin (Figure 1A), endothelin I (Figure 1B), and phenylephrine (Figure 1C) for both mesenteric artery rings with (+) fat and without (–) fat. At a concentration of 2 µmol/L serotonin, 10 nmol/L endothelin I, and 300 nmol/L phenylephrine, the contractile response of intact rings was 50%, 60%, and 80% lower than that of vessels without periadventitial fat. Endothelial removal did not influence the anticontractile effects of periadventitial fat (Figure IA online). These results provide evidence for a vasodilatory, or rather anticontractile, effect of periadventitial adipose tissue. We next tested the hypothesis that the anticontractile effect of periadventitial fat depends on the amount of fat on each ring. Figure 1D shows contractile responses to 2 µmol/L serotonin of mesenteric artery rings without (–) fat, mesenteric artery rings after longitudinal removal of 50% periadventitial adipose tissue (1/2 fat), and intact (+) fat mesenteric artery ring preparations. Thus, the inhibition of the contractile response to serotonin by fat depends on the amount of fat on each ring.



View larger version (40K):
[in this window]
[in a new window]
 
Figure 1. Dose-response curves to serotonin (A), endothelin I (B), and phenylephrine (C) in intact (+) fat preparations ({circ}) and (–) fat preparations without periadventitial fat (•). Contraction induced by 2 µmol/L serotonin of mesenteric rings without (–) fat, mesenteric (1/2 fat) rings after longitudinal removal of 50% periadventitial adipose tissue along the ipsilateral side, and intact (+) fat mesenteric ring preparations (D). *P<0.05.

Involvement of K+ Channels
We next tested the hypothesis that K+ channels are involved in this anticontractile effect. We challenged (+) fat rings and (–) fat rings (n=26) with 60 mmol/L KCl and 45 mmol/L KCl. Raising external K+ would be expected to diminish the effects of any K+ channel opener by substantially reducing the difference between the K+ equilibrium potential and the membrane potential.6,7 Figure 2A shows that the contractile responses of (+) fat vessels and (–) fat vessels to 60 mmol/L KCl were not significantly different. Figure IB shows that 45 mmol/L KCl induced smaller submaximal contractions, but the contractile responses of (+) fat vessels and (–) fat vessels to 45 mmol/L KCl were not significantly different. These findings demonstrate that excitation-contraction coupling in intact arteries and arteries lacking periadventitial fat remain functional and that the presence of periadventitial fat does not mechanically or otherwise alter the contractility of artery rings. In addition, the synthetic K+ channel opener cromakalim7,8 at 0.1 µmol/L (n=5) did not reduce 60 mmol/L KCl–induced contractions in (+) fat vessels and (–) fat vessels (not shown). However, cromakalim at 0.1 µmol/L almost completely relaxed contractions of (+) fat vessels and (–) fat vessels to 2 µmol/L serotonin (Figure 2B). Thus, KATP channels are functional and membrane hyperpolarization of the smooth muscle cells can reverse serotonin-dependent contractions. The results suggest that the difference in response to serotonin between intact vessels and vessels without periadventitial fat is dependent on opening of K+ channels.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. Reducing the difference between the K+ equilibrium potential and the membrane potential by application of isotonic bath solution containing 60 mmol/L KCl (A) abolished the difference in contractile response between (+) fat ({blacksquare}) and (–) fat ({square}) rings. Opening of KATP channels by cromakalim (Croma, 100 nmol/L) induced complete relaxation of serotonin (5-HT)-precontracted (+) fat mesenteric rings and (–) fat mesenteric rings (B). Dose-response curves to U46619 (C) in intact (+) fat preparations ({circ}) and (–) fat preparations without fat (•). The presence of fat did not reduce the contractile response to this agonist. Opening of KATP channels by cromakalim did not induce relaxation of U46619-precontracted (+) fat ({blacksquare}) mesenteric rings and (–) fat ({square}) mesenteric rings (D). *P<0.05; n.s. indicates not significant.

We next challenged (+) fat rings and (–) fat rings (n=6) with the thromboxane A2 analogue U46619. U46619 induces vascular contraction that is largely independent of vascular smooth muscle cell membrane potential changes. Thus, U44619-dependent contractions are resistant to opening of K+ channels in vascular smooth muscle cells.9 We generated dose-response curves to U44619 for intact (+) fat, n=6), and mesenteric artery rings without (–) fat, n=6). Figure 2C shows that the contractile responses of (+) fat vessels and (–) fat vessels to U44619 were not significantly different. In addition, cromakalim at 0.1 µmol/L had no effect on the contractile responses of (+) fat vessels and (–) fat vessels to 0.1 µmol/L U44619 (Figure 2D). These results are in line with our previous data indicating that the difference in contractile response to serotonin between intact vessels and vessels without periadventitial fat is dependent on opening of K+ channels.

Role of Kv Channels
To explore the nature of K+ channels involved in the fat-modulated response of mesenteric ring contraction, we tested different blockers of K+ channels present in rat mesenteric arteries. At 2 mmol/L, the Kv channel blocker 4-aminopyridine (4-AP)10–12 virtually abolished the difference in response between intact (+) fat vessels and vessels without (–) fat (n=6) to serotonin (Figure 3A and Figure IIA online). The Kv channel blocker 3,4-diaminopyridine (3,4-DAP)13 at 1 mmol/L had similar effects (n=5, Figure 3B and Figure IIB). The small-conductance, Ca2+-activated K+ channel blocker apamin4 (1 µmol/L, n=6; Figure 4A and Figure IIC) and the KATP channel blocker glibenclamide10,14 (3 µmol/L, n=8; Figure 4B and Figure IID) were not effective. The inward rectifier K+ channel blocker Ba2+ (3 µmol/L)11 did not influence the anticontractile effect of fat (n=6, Figure III online). These results suggest that the difference in response to serotonin between intact vessels and vessels lacking periadventitial fat is most likely mediated by opening of Kv channels in vascular smooth muscle cells. Blockers of large-conductance, Ca2+-activated potassium channels, that is, iberiotoxin10,14–16 (100 nmol/L, n=6, Figure IVA online) and tetraethylammonium10,14,16 (TEA; 1 mmol/L, n=6, Figure IVB), and tetrapentylammonium,17 which also blocks KATP channels,18 (2 µmol/L, n=6, not shown) enhanced serotonin-dependent contractions by 20% to 30% in both (–) fat and (+) fat rings. These results suggest that large-conductance Ca2+-activated K+ channels limit serotonin-dependent contractions of both (+) fat and (–) fat rings. However, the data also indicate that the difference in response to serotonin between intact (+) fat vessels and (–) fat vessels is not mediated by opening of large-conductance Ca2+-activated K+ channels in vascular smooth muscle cells.



View larger version (39K):
[in this window]
[in a new window]
 
Figure 3. Blockers of voltage-dependent, delayed-rectifier K+ channels inhibited the anticontractile effect of periadventitial fat on the response to serotonin. A, Representative experiment showing that 4-AP (2 mmol/L) enhanced the contractile response to serotonin (5-HT, 2 µmol/L) in (+) fat rings but not in (–) fat rings. B, Representative experiment showing that 3,4-DAP (1 mmol/L) enhanced the contractile response to serotonin (5-HT, 2 µmol/L) in (+) fat rings but not in (–) fat rings. The intracellular membrane potential of vascular smooth muscle cells in (+) fat rings is hyperpolarized in comparison to (–) fat rings (C, left); 4-AP (2 mmol/L) inhibited the difference (C, right). *P<0.05.



View larger version (51K):
[in this window]
[in a new window]
 
Figure 4. A, Representative experiment showing that apamin (1 µmol/L) did not affect the contractile response to serotonin (5-HT, 2 µmol/L) in (+) fat rings and (–) fat rings. B, Representative experiment showing that glibenclamide (3 µmol/L) did not affect the contractile response to serotonin (5-HT, 2 µmol/L) in (+) fat rings and (–) fat rings.

To confirm the conclusion that 4-AP–sensitive, voltage-dependent K+ channels in arterial smooth muscle cells are involved in the anticontractile effects of fat, we measured the intracellular vascular smooth muscle cell membrane potential of (+) fat rings and (–) fat rings. Figure 3C shows that the intracellular membrane potentials were more hyperpolarized in (+) fat rings than in (–) fat rings (n=12 each). At 2 mmol/L, 4-AP virtually abolished the difference in intracellular membrane potential between intact (+) fat vessels and vessels without (–) fat (n=12 each).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
We found that periadventitial fat significantly attenuates vascular responsiveness of mesenteric arteries to several hormonal agonists, including serotonin, phenylephrine, and endothelin I. Our data suggest that visceral periadventitial adipose tissue controls mesenteric arterial tone by activating voltage-dependent, delayed-rectifier K+ (Kv) channels that hyperpolarize the vascular smooth muscle cell membrane. The mechanisms we describe here are distinct from those we described earlier from aortic preparations, where KATP channels were primarily involved. Because we studied superior mesenteric arteries that contribute to the regulation of mesenteric blood flow and to peripheral resistance, perturbations in Kv channel regulation could conceivably contribute to blood pressure elevation in obesity-related hypertension.

Inhibition of the contractile response to serotonin by fat depended on the amount of fat on each ring. The effects were not dependent on the endothelium. We studied the possible involvement of plasma membrane K+ channels in detail. We found that the anticontractile effect of periadventitial fat was not abolished by inhibition of KATP channels, small-conductance Ca2+-activated K+ channels, and inward rectifying K+ channels. However, we found that the anticontractile effect of periadventitial fat was abolished by inhibition of Kv channels. The resting membrane potential of smooth muscle cells in intact mesenteric artery rings was more hyperpolarized than in mesenteric artery rings without periadventitial fat, a difference that was abolished by Kv channel inhibition with 4-AP. Together, these results suggest that visceral periadventitial adipose tissue controls mesenteric arterial tone locally. We suggest that vascular smooth muscle cell Kv channels are involved in the anticontractile effects of periadventitial adipose tissue.

Patch-clamp studies have shown that slowly-inactivating Kv channels are expressed in smooth muscle cells of our preparation. These channels are sensitive to 4-APand 3,4-DAP19–22 but not to TEA.22,23 In contrast to smooth muscle cells, Kv channels in adipocytes are rapidly-inactivating, sensitive to TEA,24–26 and relatively resistant to 4-AP.27–29 Ba2+-sensitive inward rectifying K+ have not been detected in adipocytes. In addition, we found that the intracellular membrane potential was more negative in smooth muscle cells of (+) fat rings compared with (–) fat rings, a difference that was abolished by 4-AP. We tried to measure the intracellular membrane potential in adipocytes of (+) fat rings. Unfortunately, this was technically impossible; this might also be the reason that there is no publication on intracellular membrane potential measurement in perivascular adipocytes. Taken together, the data are consistent with the idea that Kv channels in smooth muscle cells are involved in the anticontractile effect of adipose tissue.

In contrast to aorta, KATP channels were not involved in the mesenteric artery periadvential fat effect. A possible explanation is that KATP channels in aortic and mesenteric smooth muscle are different, as large-conductance KATP channels ({approx}130 pS, in symmetric high K+) sensitive to intracellular [ATP] have been found in aorta but not in mesenteric arteries.30–32 In rat mesenteric arteries, small-conductance KATP (KNDP) channels ({approx}25 pS, in symmetric high K+) have been identified that are regulated by nucleoside diphosphates (UDP or GDP) and ATP acting from the inside.33,34 The molecular identity of the aortic and mesenteric KATP channels is not absolutely established. Two Kir6.x subunits have been cloned to date: Kir6.1 and Kir6.2 that differ in their single channel conductance. Three major types of sulfonylurea receptor have been cloned, SUR1, SUR2A, and SUR2B, although other splice variants also exist. The properties of a particular KATP channel are dependent on its subunit composition. KNDP channels seem to be equivalent to the Kir6.1/SUR2B channel,35 whereas the molecular composition of aortic KATP channels is less clear.36–38 Based on their molecular diversity, it is possible that aortic and mesenteric KATP channels respond differently to ADRF. Alternatively, visceral periadventitial adipose tissue may produce a number of ADRFs or involve different ADRF receptors and intracellular second messengers to control vascular tone in different vascular beds.

Perspectives
We demonstrate an important functional role of periadventitial adipose tissue on mesenteric artery tone. We suggest that vascular smooth muscle cell Kv channels regulate the process. Identification of the putative ADRF may shed light on obesity-related hypertension and could possibly be of therapeutic importance.


*    Acknowledgments
 
The Deutsche Forschungsgemeinschaft and Deutsche Akademische Austauschdienst supported this work. We thank Diana Herold for excellent technical assistance and data analysis.

Received March 25, 2004; first decision April 8, 2004; accepted June 18, 2004.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A. 1991; 13: 277–296.[Medline] [Order article via Infotrieve]

2. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002; 16: 1057–1063.[Abstract/Free Full Text]

3. Tsang SY, Yao X, Wong CM, Au CL, Chen ZY, Huang Y. Contribution of Na+ -Ca2+ exchanger to pinacidil-induced relaxation in the rat mesenteric artery. Br J Pharmacol. 2003; 138: 453–460.[CrossRef][Medline] [Order article via Infotrieve]

4. Tsang SY, Yao X, Chan HY, Wong CM, Chen ZY, Au CL, Huang Y. Contribution of K+ channels to relaxation induced by 17beta-estradiol but not by progesterone in isolated rat mesenteric artery rings. J Cardiovasc Pharmacol. 2003; 41: 4–13.[CrossRef][Medline] [Order article via Infotrieve]

5. Gonzalez MC, Arribas SM, Molero F, Fernandez-Alfonso MS. Effect of removal of adventitia on vascular smooth muscle contraction and relaxation. Am J Physiol Heart Circ Physiol. 2001; 280: H2876–H2881.[Abstract/Free Full Text]

6. Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature. 1990; 344: 770–773.[CrossRef][Medline] [Order article via Infotrieve]

7. Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989; 245: 177–180.[Abstract/Free Full Text]

8. McCarron JG, Quayle JM, Halpern W, Nelson MT. Cromakalim and pinacidil dilate small mesenteric arteries but not small cerebral arteries. Am J Physiol. 1991; 261: H287–H291.[Medline] [Order article via Infotrieve]

9. McPherson GA, Keily SG, Angus JA. Spasmolytic effect of cromakalim in dog coronary artery in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1991; 343: 519–524.[Medline] [Order article via Infotrieve]

10. Gollasch M, Ried C, Bychkov R, Luft FC, Haller H. K+ currents in human coronary artery vascular smooth muscle cells. Circ Res. 1996; 78: 676–688.[Abstract/Free Full Text]

11. Robertson BE, Bonev AD, Nelson MT. Inward rectifier K+ currents in smooth muscle cells from rat coronary arteries: block by Mg2+, Ca2+, and Ba2+. Am J Physiol. 1996; 271: H696–H705.[Medline] [Order article via Infotrieve]

12. Knot HJ, Nelson MT. Regulation of arterial diameter and wall [Ca2+] in cerebral arteries of rat by membrane potential and intravascular pressure. J Physiol. 1998; 508 (Pt 1): 199–209.[Abstract/Free Full Text]

13. Robertson BE, Nelson MT. Aminopyridine inhibition and voltage dependence of K+ currents in smooth muscle cells from cerebral arteries. Am J Physiol. 1994; 267: C1589–C1597.[Medline] [Order article via Infotrieve]

14. Nelson MT, Brayden JE. Regulation of arterial tone by calcium-dependent K+ channels and ATP-sensitive K+ channels. Cardiovasc Drugs Ther. 1993; 7 (Suppl 3): 605–610.[CrossRef][Medline] [Order article via Infotrieve]

15. Schubert R, Nelson MT. Protein kinases: tuners of the BKCa channel in smooth muscle. Trends Pharmacol Sci. 2001; 22: 505–512.[CrossRef][Medline] [Order article via Infotrieve]

16. Rusch NJ, Liu Y, Pleyte KA. Mechanisms for regulation of arterial tone by Ca2+-dependent K+ channels in hypertension. Clin Exp Pharmacol Physiol. 1996; 23: 1077–1081.[Medline] [Order article via Infotrieve]

17. Bychkov R, Gollasch M, Ried C, Luft FC, Haller H. Effects of pinacidil on K+ channels in human coronary artery vascular smooth muscle cells. Am J Physiol. 1997; 273: C161–C171.[Medline] [Order article via Infotrieve]

18. Kovacs RJ, Nelson MT. ATP-sensitive K+ channels from aortic smooth muscle incorporated into planar lipid bilayers. Am J Physiol. 1991; 261: H604–H609.[Medline] [Order article via Infotrieve]

19. Lu Y, Zhang J, Tang G, Wang R. Modulation of voltage-dependent K+ channel current in vascular smooth muscle cells from rat mesenteric arteries. J Membr Biol. 2001; 180: 163–175.[CrossRef][Medline] [Order article via Infotrieve]

20. Cox RH, Lozinskaya I, Dietz NJ. Differences in K+ current components in mesenteric artery myocytes from WKY and SHR. Am J Hypertens. 2001; 14: 897–907.[CrossRef][Medline] [Order article via Infotrieve]

21. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol. 1990; 259: C3–C18.[Medline] [Order article via Infotrieve]

22. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268: C799–C822.[Medline] [Order article via Infotrieve]

23. Smirnov SV, Aaronson PI. Ca(2+)-activated and voltage-gated K+ currents in smooth muscle cells isolated from human mesenteric arteries. J Physiol. 1992; 457: 431–454.[Abstract/Free Full Text]

24. Ramirez-Ponce MP, Mateos JC, Bellido JA. Human adipose cells have voltage-dependent potassium currents. J Membr Biol. 2003; 196: 129–134.[CrossRef][Medline] [Order article via Infotrieve]

25. Russ U, Ringer T, Siemen D. A voltage-dependent and a voltage-independent potassium channel in brown adipocytes of the rat. Biochim Biophys Acta. 1993; 1153: 249–256.[Medline] [Order article via Infotrieve]

26. Ringer E, Russ U, Siemen D. Beta(3)-adrenergic stimulation and insulin inhibition of non-selective cation channels in white adipocytes of the rat. Biochim Biophys Acta. 2000; 1463: 241–253.[Medline] [Order article via Infotrieve]

27. Ramirez-Ponce MP, Mateos JC, Carrion N, Bellido JA. Voltage-dependent potassium channels in white adipocytes. Biochem Biophys Res Commun. 1996; 223: 250–256.[CrossRef][Medline] [Order article via Infotrieve]

28. Ramirez-Ponce MP, Mateos JC, Bellido JA. Insulin increases the density of potassium channels in white adipocytes: possible role in adipogenesis. J Endocrinol. 2002; 174: 299–307.[Abstract]

29. Wilson SM, Lee SC, Shook S, Pappone PA. ATP and beta-adrenergic stimulation enhance voltage-gated K current inactivation in brown adipocytes. Am J Physiol Cell Physiol. 2000; 279: C1847–C1858.[Abstract/Free Full Text]

30. Matzno S, Sato R, Takai H, Aida Y, Karasaki S, Oyaizu M, Nakamura N, Katori R. The effect of AL0671, a novel potassium channel opener, on potassium current in rat aortic smooth muscle cells. Gen Pharmacol. 1995; 26: 1327–1334.[Medline] [Order article via Infotrieve]

31. Janigro D, West GA, Gordon EL, Winn HR. ATP-sensitive K+ channels in rat aorta and brain microvascular endothelial cells. Am J Physiol. 1993; 265: C812–C821.[Medline] [Order article via Infotrieve]

32. Quayle JM, Bonev AD, Brayden JE, Nelson MT. Pharmacology of ATP-sensitive K+ currents in smooth muscle cells from rabbit mesenteric artery. Am J Physiol. 1995; 269: C1112–1118.[Medline] [Order article via Infotrieve]

33. Zhang H, Bolton TB. Activation by intracellular GDP, metabolic inhibition and pinacidil of a glibenclamide-sensitive K-channel in smooth muscle cells of rat mesenteric artery. Br J Pharmacol. 1995; 114: 662–672.[Medline] [Order article via Infotrieve]

34. Davie CS, Kubo M, Standen NB. Potassium channel activation and relaxation by nicorandil in rat small mesenteric arteries. Br J Pharmacol. 1998; 125: 1715–1725.[CrossRef][Medline] [Order article via Infotrieve]

35. Wang X, Wu J, Li L, Chen F, Wang R, Jiang C. Hypercapnic acidosis activates KATP channels in vascular smooth muscles. Circ Res. 2003; 92: 1225–1232.[Abstract/Free Full Text]

36. Ren YJ, Xu XH, Zhong CB, Feng N, Wang XL. Hypercholesterolemia alters vascular functions and gene expression of potassium channels in rat aortic smooth muscle cells. Acta Pharmacol Sin. 2001; 22: 274–278.[Medline] [Order article via Infotrieve]

37. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 2002; 8: 466–472.[CrossRef][Medline] [Order article via Infotrieve]

38. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marban E, Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res. 2001; 88: 570–577.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. R. Dashwood, K. Savage, J. C.S. Tsui, A. Dooley, S. G. Shaw, M. S. Fernandez Alfonso, L. Bodin, and D. S.R. Souza
Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity.
J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 334 - 340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Xiang and R. L. Hester
Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H689 - H695.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. A. Payne, H. G. Bohlen, U. D. Dincer, L. Borbouse, and J. D. Tune
Periadventitial adipose tissue impairs coronary endothelial function via PKC-{beta}-dependent phosphorylation of nitric oxide synthase
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H460 - H465.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. S. Greenstein, K. Khavandi, S. B. Withers, K. Sonoyama, O. Clancy, M. Jeziorska, I. Laing, A. P. Yates, P. W. Pemberton, R. A. Malik, et al.
Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients
Circulation, March 31, 2009; 119(12): 1661 - 1670.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. K. Chatterjee, L. L. Stoll, G. M. Denning, A. Harrelson, A. L. Blomkalns, G. Idelman, F. G. Rothenberg, B. Neltner, S. A. Romig-Martin, E. W. Dickson, et al.
Proinflammatory Phenotype of Perivascular Adipocytes: Influence of High-Fat Feeding
Circ. Res., February 27, 2009; 104(4): 541 - 549.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
B Galvez-Prieto, J Bolbrinker, P Stucchi, A I de las Heras, B Merino, S Arribas, M Ruiz-Gayo, M Huber, M Wehland, R Kreutz, et al.
Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue
J. Endocrinol., April 1, 2008; 197(1): 55 - 64.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. A. Rosito, J. M. Massaro, U. Hoffmann, F. L. Ruberg, A. A. Mahabadi, R. S. Vasan, C. J. O'Donnell, and C. S. Fox
Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study
Circulation, February 5, 2008; 117(5): 605 - 613.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Malinowski, M. A. Deja, K. S. Golba, T. Roleder, J. Biernat, and S. Wos
Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor
Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al.
Uterine Vascular Function in a Transgenic Preeclampsia Rat Model
Hypertension, February 1, 2008; 51(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Thalmann and C. A. Meier
Local adipose tissue depots as cardiovascular risk factors
Cardiovasc Res, September 1, 2007; 75(4): 690 - 701.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Fesus, G. Dubrovska, K. Gorzelniak, R. Kluge, Y. Huang, F. C. Luft, and M. Gollasch
Adiponectin is a novel humoral vasodilator
Cardiovasc Res, September 1, 2007; 75(4): 719 - 727.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Takemori, Y.-J. Gao, L. Ding, C. Lu, L.-Y. Su, W.-S. An, C. Vinson, and R. M.K.W. Lee
Elevated Blood Pressure in Transgenic Lipoatrophic Mice and Altered Vascular Function
Hypertension, February 1, 2007; 49(2): 365 - 372.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. U. Momin, N. Melikian, A. M. Shah, D. J. Grieve, S. B. Wheatcroft, L. John, A. El Gamel, J. B. Desai, T. Nelson, C. Driver, et al.
Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance
Eur. Heart J., October 1, 2006; 27(19): 2294 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-J. Gao, K. Takemori, L.-Y. Su, W.-S. An, C. Lu, A. M. Sharma, and R. M.K.W. Lee
Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion
Cardiovasc Res, July 15, 2006; 71(2): 363 - 373.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Galvez, J. de Castro, D. Herold, G. Dubrovska, S. Arribas, M. C. Gonzalez, I. Aranguez, F. C. Luft, M. P. Ramos, M. Gollasch, et al.
Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats
Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1297 - 1302.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Davis, G. Valacchi, E. Pagnin, Q. Shao, H. B. Gross, L. Calo, and W. Yokoyama
Walnuts Reduce Aortic ET-1 mRNA Levels in Hamsters Fed a High-Fat, Atherogenic Diet
J. Nutr., February 1, 2006; 136(2): 428 - 432.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Benkirane, E. C. Viel, F. Amiri, and E. L. Schiffrin
Peroxisome Proliferator-Activated Receptor {gamma} Regulates Angiotensin II-Stimulated Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Blood Vessels In Vivo
Hypertension, January 1, 2006; 47(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Barandier, J.-P. Montani, and Z. Yang
Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1807 - H1813.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark
Obesity-Associated Hypertension: New Insights Into Mechanisms
Hypertension, January 1, 2005; 45(1): 9 - 14.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. S. Fernandez-Alfonso
Regulation of Vascular Tone: The Fat Connection
Hypertension, September 1, 2004; 44(3): 255 - 256.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
44/3/271    most recent
01.HYP.0000140058.28994.ecv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verlohren, S.
Right arrow Articles by Gollasch, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verlohren, S.
Right arrow Articles by Gollasch, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*4-AMINOPYRIDINE
*BARIUM COMPOUNDS
*BARIUM, ELEMENTAL
*PHENYLEPHRINE
*POTASSIUM
Related Collections
Right arrow Lipids
Right arrow Obesity
Right arrow Hypertension - basic studies
Right arrow Ion channels/membrane transport
Right arrow Other Vascular biology